Introduction {#section5-1179548420901518}
============

Intravenous fluid resuscitation is a key piece in the management of patients with circulatory shock.^[@bibr1-1179548420901518]^ Fluid loading aims to increase cardiac output (CO) to improve the convective transport of oxygen to the tissues. Nevertheless, fluids can be harmful when excessively administered.^[@bibr2-1179548420901518]^ Indeed, higher fluid balances have been related to adverse clinical outcomes in septic shock,^[@bibr3-1179548420901518]^ whereby strategies to prevent fluid overload are highly desirable and represent a priority in sepsis research.^[@bibr4-1179548420901518]^

Prediction of fluid response could potentially avoid unnecessary volume load during resuscitation of circulatory shock. Several tools can be used to predict the increase in CO after a fluid load^[@bibr5-1179548420901518]^ and potentially, some of these might improve clinical outcomes when incorporated as a part of treatment algorithms of intravenous fluid management.^[@bibr6-1179548420901518][@bibr7-1179548420901518][@bibr8-1179548420901518][@bibr9-1179548420901518]-[@bibr10-1179548420901518]^ Pulse pressure variation (PPV) can predict fluid responsiveness in critically ill patients,^[@bibr11-1179548420901518][@bibr12-1179548420901518]-[@bibr13-1179548420901518]^ and although with some limitations, it might better predict fluid responsiveness than stroke volume and systolic pressure variations.^[@bibr11-1179548420901518]^

Mechanical ventilation with low tidal volumes is widely recommended in patients with acute respiratory distress syndrome^[@bibr14-1179548420901518]^ and other many circumstances in critical care.^[@bibr15-1179548420901518]^ Nevertheless, the operative performance of PPV may be substantially reduced when mechanical ventilation is set at low tidal volumes^[@bibr16-1179548420901518]^ or when lung compliance is severely compromised^[@bibr17-1179548420901518]^ because, under such conditions, the effects of mechanical ventilation on the cardiac extramural and intramural pressures are limited. Besides, at higher respiratory rates (RR) and low heart to RR ratios, the usefulness of PPV could also be limited^[@bibr18-1179548420901518],[@bibr19-1179548420901518]^

Although several meta-analyses and systematic reviews have described the operative performance of PPV as a predictor of fluid responsiveness, the particular usefulness of PPV under Vt ⩽8 mL kg^−1^ and high heart rate to RR ratio is controversial. Thus, we propose to perform a meta-analysis and systematic review about the performance of PPV as a predictor of fluid responsiveness in adult patients ventilated at tidal volume ⩽8 mL kg^−1^ without arrhythmias and active respiratory efforts in the critical care and perioperative settings.

Methodology {#section6-1179548420901518}
===========

Protocol {#section7-1179548420901518}
--------

This systematic review was conducted by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations.^[@bibr20-1179548420901518]^

Study selection and inclusion criteria {#section8-1179548420901518}
--------------------------------------

We look for prospective studies assessing the operative performance of PPV as a predictor of fluid responsiveness in the critical care and perioperative adult patients ventilated at Vt ⩽8 mL kg^−1^ without excessive respiratory efforts and arrhythmias. Only those in which PPV was used as a predictor of fluid responsiveness and revealing data about its operative performance were finally included for analysis. Indeed, an explicit definition of fluid responsiveness and the percentage of fluid response should also be revealed to be included. Only manuscripts written in English were selected. We did not include studies including patients younger than 18 years of age or pregnant women. We also did not include case reports, studies in abstract form, or studies conducted in animals.

Search strategy and data extraction {#section9-1179548420901518}
-----------------------------------

A highly sensitive search strategy was conducted in Embase and in MEDLINE using the PubMed interface from January 1990 to January 2019. We applied no restrictions apart of language restrictions (as previously described). Data extraction and eligibility assessment were performed independently in an unblinded, standardized manner by 2 reviewers (J.I.A.S. and J.D.C.R.). We used the following terms: ("pulse pressure variation" \[All Field\] OR "Fluid Challenge" \[All field\]) AND (respiration \[MeSH\] OR Respiration, Artificial \[MeSH\] OR Respiratory Distress Syndrome, Adult \[MeSH\] OR Tidal volume \[MeSH\] OR Lung Compliance \[MeSH\]) filtered by full text.

Study selection and data collection process {#section10-1179548420901518}
-------------------------------------------

Two authors (J.I.A.S. and J.D.C.R.) reviewed titles independently and abstracts potentially eligible. Those studies fulfilling the inclusion criteria were pooled in a list, and then, the 2 files were compared to select those to be finally included for analysis. We also search for additional studies using the bibliography of previously chosen studies. Any disagreement between the authors was resolved through discussion; if it continued, a third author reviewed the article and facilitated a consensus among all review authors.

Data items {#section11-1179548420901518}
----------

Data extracted from each clinical trial included authors, year of publication, type of population (critical or surgical) enrolled in the trial, type of study, number of patients enrolled, device or technique used to determinate PPV; type and volume of fluid used during the fluid loading; operational definition of intravenous fluid responsiveness; percentage of positive fluid response; cut-off point of PPV used; ventilatory settings (particularly tidal volume, RR, and lung compliance); finally, data about sensitivity, specificity, and area under the curve (AUC) reported for PPV.

Quality assessment {#section12-1179548420901518}
------------------

The quality of studies was assessed by the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) using 4 domains: patient selection, index test, reference standard, and flow and time. Each area was assessed for risk of bias, classified as "low," "high," or "unclear." Besides, its risk of applicability had 3 domains: patient selection, index test, and reference standard, which were assessed as "low," "high," or "unclear."^[@bibr21-1179548420901518]^

Statistical analysis {#section13-1179548420901518}
--------------------

### Analysis of individual studies {#section14-1179548420901518}

The data of sensitivity, specificity, diagnostic odds ratio (DOR) were calculated by a contingency table.

### Analysis of summary measures {#section15-1179548420901518}

The pooled data of sensitivity, specificity, DOR were assessed by the random-effects methods. The fitted data of sensitivity, specificity, and AUC were assessed by bivariate and hierarchical analyses. The summary receiver operating characteristic (ROC) curve was evaluated by the Rutter and Gatsonis method. An area under curve receiver operating (AUROC) greater than 0.7 would mean a fair operative performance.^[@bibr22-1179548420901518]^

The heterogeneity of trials was assessed by Cochran *Q* statistics; its effects were quantified using inconsistency (*I*^2^). *I*^2^ greater than 50% would mean significant heterogeneity.^[@bibr23-1179548420901518]^

### Analysis of risk of bias across studies {#section16-1179548420901518}

Asymmetry was assessed by a contour-enhanced funnel plot and by the Thompson and Sharp tests. Publication bias was fitted by the trim-and-fill method.

### Additional analysis {#section17-1179548420901518}

We performed a subgroup and meta-regression analysis to assess the association between clinical setting, lung compliance, variable measured to determine fluid responsiveness, a method for indices, type of fluid, hemodynamic endpoint, outlier studies, and tidal volume used, and DOR and Log-DOR. The threshold effect was assessed by Spearman rank correlation coefficient and by the Moses-Shapiro-Littenberg method.

The data were analyzed using R version 3.4.3 with the mada and meta packages. The data are expressed as a value (95% confidence interval \[CI\]). *P* \< .05 was considered statistically significant.

Results {#section18-1179548420901518}
=======

Study selection {#section19-1179548420901518}
---------------

From a total of 255 studies, we finally retrieved 19 fulfilling all inclusion criteria and providing complete information about mechanical ventilation settings. The complete searching process is depicted in [Figure 1](#fig1-1179548420901518){ref-type="fig"}.

![Adapted from Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009).^[@bibr20-1179548420901518]^](10.1177_1179548420901518-fig1){#fig1-1179548420901518}

Study characteristics {#section20-1179548420901518}
---------------------

A total of 19 studies were incorporated in the meta-analysis; these included 18 prospective cohort studies and 1 cross-sectional study for a total of 777 patients. General characteristics are summarized in [Tables 1](#table1-1179548420901518){ref-type="table"} and [2](#table2-1179548420901518){ref-type="table"}. A total of 935 fluid challenges were performed, with an average of fluid responsiveness of 51.51%. Seven studies were performed in a surgical setting, whereas 12 were conducted in the critical care setting. Eight studies used crystalloids, 8 used colloids, and 3 used both fluids during the fluid loads. Cardiac output was determined by different methods: pulmonary artery catheter (PAC) (n = 7), Pulse Contour Cardiac Output (PiCCO and PiCCO2) (n = 7), ProAQT (n = 2), PAC or PiCCO (n = 2), and Lithium Dilution Cardiac Output (LiDCO) (n = 1). A positive response to fluids was considered when CO, stroke volume index, or cardiac index increase \>15% in 15 studies and \>10% in 4 studies.

###### 

Select characteristics of included studies.

![](10.1177_1179548420901518-table1)

  Order   Authors                                             Year   Setting                            Type of study                   Sample size   No. of fluid challenge   Method for indices   Infusion volume                         Hemodynamic end point   Tidal volume, mL kg^−1^   Compliance, mL cm H~2~O^−1^)
  ------- --------------------------------------------------- ------ ---------------------------------- ------------------------------- ------------- ------------------------ -------------------- --------------------------------------- ----------------------- ------------------------- -------------------------------------------------------------------------
  1       De Backer et al.^[@bibr16-1179548420901518]^        2005   Critically ill patients            Prospective cohort              33            33                       PAC                  1000 mL CR or 500 mL HES 10%            Increase in CI ⩾ 15%    6.3 (6.0-7.1)             26.0 (23.0-33.0)
  2       Huang et al.^[@bibr24-1179548420901518]^            2008   Critically ill patients            Prospective cohort              22            22                       PAC                  500 mL HES                              Increase in CI ⩾ 15%    6.4 (5.7-1)7.             26.1 (18.5-33.7)
  3       Auler et al.^[@bibr25-1179548420901518]^            2008   Post cardiac surgery               Prospective cohort              59            59                       PAC                  20 mL kg^-1^ LR                         Increase in CI ⩾ 15%    8.0                       NR
  4       Vallée et al.^[@bibr26-1179548420901518]^           2009   Critically ill patients            Prospective cohort              42            42                       PiCCO                6 mL kg^−1^ HES                         Increase in CI ⩾ 15%    6.0 (6.2-7.3)             27.0 (23.0-35.0)
  5       Muller et al.^[@bibr18-1179548420901518]^           2010   Critically ill patients            Prospective cohort              57            57                       PAC o PiCCO          250 or 500 mL saline or HES             Increase in SVI ⩾ 15%   6.0 (4.8-7.8) IBW         28.0^[a](#table-fn3-1179548420901518){ref-type="table-fn"}^
  6       Lakhal et al.^[@bibr19-1179548420901518]^           2011   Critically ill patients            Prospective cohort?             65            65                       PAC o PiCCO          500 mL of gelatin                       Increase in CO ⩾ 10%    6.9 (5.95-7.85) PBW       40.4 (24.6-56.2)
  7       Oliveira-Costa et al.^[@bibr27-1179548420901518]^   2012   Critically ill patients            Cross-sectional observational   37            37                       PAC                  1000 mL saline or LR or 500 mL HES 6%   Increase in CI ⩾ 15%    6.5 (6.0-6.5) IBW         34.0 (19.0-49.0)
  8       Monnet et al.^[@bibr17-1179548420901518]^           2012   Critically ill patients            Prospective cohort              28            28                       PiCCO2               500 mL saline                           Increase in CI ⩾ 15%    7.1 (6.3-7.9) PBW         23.0 (20.0-26.0)
  9       Yazigi et al.^[@bibr28-1179548420901518]^           2012   Post cardiac surgery               Prospective cohort              60            60                       PAC                  7 mL kg^−1^ HES                         Increase in SVI ⩾ 15%   8.0                       NR
  10      Cecconi et al.^[@bibr29-1179548420901518]^          2012   Post high-risk surgery             Prospective cohort              31            47                       LiDCO                250 mL colloid                          Increase in SV ⩾ 15%    8.0 IBW                   NR
  11      Freitas et al.^[@bibr30-1179548420901518]^          2013   Critically ill patients            Prospective cohort              40            40                       PAC                  7 mL kg^−1^ HES                         Increase in CO ⩾ 15%    6.0 PBW                   31.0 (23.6-37.9)
  12      Trepte et al.^[@bibr31-1179548420901518]^           2013   Intraoperative high-risk surgery   Prospective cohort              24            72                       PiCCO2               300 mL HES                              Increase in CI ⩾ 10%    8.0                       NR
  13      Song et al.^[@bibr32-1179548420901518]^             2014   Intraoperative---cardiac surgery   Prospective cohort              40            40                       PAC                  6 mL kg^−1^ HES                         Increase in SVI ⩾ 15%   8.0 IBW                   NR
  14      Ibarra-Estrada et al.^[@bibr33-1179548420901518]^   2015   Critically ill patients            Prospective cohort              19            59                       PiCCO                7 mL kg^−1^ saline                      Increase in SVI ⩾ 15%   6.0 (6.0-6.3) PBW         NR
  15      Liu et al.^[@bibr34-1179548420901518]^              2016   Critically ill patients            Prospective cohort              96            96                       PiCCO                500 mL saline                           Increase in CO ⩾ 15%    7.0 (6.2-7.8) mL kg^−1^   28.0 (15.9-40.1)^[a](#table-fn3-1179548420901518){ref-type="table-fn"}^
  16      Myatra et al.^[@bibr35-1179548420901518]^           2017   Critically ill patients            Prospective cohort              20            30                       PiCCO                7 mL kg^-1^ saline                      Increase in CI ⩾ 15%    6.0 (5.8-6.2) PWB         29.0 (21.0-37.0)
  17      Biais et al.^[@bibr36-1179548420901518]^            2017   Intraoperative---neurosurgery      Prospective cohort              41            41                       ProAQT               250 mL saline                           Increase in SVI ⩾ 10%   6.8 (6.3-7.3) ± IBW       38.0 (28.0-48.0)
  18      Biais et al.^[@bibr37-1179548420901518]^            2017   Intraoperative---neurosurgery      Prospective cohort              44            88                       ProAQT               250 mL saline                           Increase in SVI ⩾ 10%   6.9 (6.5-7.2) IBW         42.2^[a](#table-fn3-1179548420901518){ref-type="table-fn"}^
  19      Yonis et al.^[@bibr38-1179548420901518]^            2017   Critically ill patients            Prospective cohort              19            19                       PiCCO                500 mL LR                               Increase in CI ⩾ 15%    6.0 PBW                   30.0 (23.0-39.0)

Abbreviations: CI, cardiac index; CO, cardiac output; CR, crystalloid; HES, hydroxyethyl starch; IBW, ideal body weight; LR, Ringer's lactate; NA, not available; NR: not reported; PAC, pulmonary artery catheter; PBW, predicted body weight; SV, stroke volume; SVI, stroke volume index; PPV, pulse pressure variation.

Values are expressed as pooled value (95% confidence interval) or median (IQR).

Calculated.

###### 

Diagnostic performance of pulse pressure variation for prediction of fluid responsiveness in patients with tidal volume ⩽8 mL kg^−1^ from included studies.

![](10.1177_1179548420901518-table2)

  Order   Authors                                             Year   tp   n1   tn   n2   nt   Sensitivity        Specificity        AUC                Threshold, %   Method use to measure PPV                    Fluid responsiveness rate, %
  ------- --------------------------------------------------- ------ ---- ---- ---- ---- ---- ------------------ ------------------ ------------------ -------------- -------------------------------------------- --------------------------------------------------------------
  1       De Backer et al.^[@bibr16-1179548420901518]^        2005   7    18   10   15   33   0.39 (0.20-0.61)   0.65 (0.42-0.85)   0.71 (0.62-0.80)   PPV ⩾ 12       Analysis of the monitored arterial tracing   55.00^[a](#table-fn6-1179548420901518){ref-type="table-fn"}^
  2       Huang et al.^[@bibr24-1179548420901518]^            2008   7    10   11   12   22   0.70 (0.40-0.89)   0.92 (0.65-0.99)   0.76               PPV ⩾ 11.8     Analysis of the monitored arterial tracing   45.45
  3       Auler et al.^[@bibr25-1179548420901518]^            2008   38   39   19   20   59   0.97 (0.87-1.00)   0.95 (0.76-0.99)   0.98 (0.97-0.99)   PPV ⩾ 12       Analysis of the monitored arterial tracing   66.10
  4       Vallée et al.^[@bibr26-1179548420901518]^           2009   6    19   17   23   42   0.32 (0.15-0.54)   0.74 (0.54-0.87)   0.63 (0.45-0.81)   PPV ⩾ 15       Analysis of the monitored arterial tracing   46.42^[a](#table-fn6-1179548420901518){ref-type="table-fn"}^
  5       Muller et al.^[@bibr18-1179548420901518]^           2010   25   41   15   16   57   0.61 (0.46-0.74)   0.94 (0.72-0.99)   0.77 (0.65-0.90)   PPV ⩾ 7        Analysis of the monitored arterial tracing   72.00
  6       Lakhal et al.^[@bibr19-1179548420901518]^           2011   19   26   33   39   65   0.73 (0.54-0.86)   0.85 (0.70-0.93)   0.75 (0.62-0.85)   PPV ⩾ 5        Analysis of the monitored arterial tracing   40.00
  7       Oliveira-Costa et al.^[@bibr27-1179548420901518]^   2012   9    17   19   20   37   0.53 (0.31-0.74)   0.95 (0.76-0.99)   0.74 (0.56-0.90)   PPV ⩾ 10       Analysis of the monitored arterial tracing   44.73
  8       Monnet et al.^[@bibr17-1179548420901518]^           2012   14   15   4    13   28   0.93 (0.79-99)0.   0.31 (0.13-58)0.   0.69 (0.68-70)0.   PPV ⩾ 4        Analysis with PiCCO2                         53.57
  9       Yazigi et al.^[@bibr28-1179548420901518]^           2012   33   41   14   19   60   0.80 (0.66-0.90)   0.74 (0.51-0.88)   0.85               PPV \>11.5     Analysis of the monitored arterial tracing   68.33
  10      Cecconi et al.^[@bibr29-1179548420901518]^          2012   10   12   14   19   31   0.83 (0.55-0.95)   0.74 (0.51-0.88)   0.87 (0.76-0.99)   PPV \>13       Analysis with LiDCO                          39.00
  11      Freitas et al.^[@bibr30-1179548420901518]^          2013   17   19   19   21   40   0.89 (0.69-0.97)   0.90 (0.71-0.97)   0.91 (0.82-1.0)    PPV ⩾ 6.5      Analysis with computer software              47.50
  12      Trepte et al.^[@bibr31-1179548420901518]^           2013   25   41   25   31   72   0.61 (0.46-0.74)   0.81 (0.64-0.91)   0.70 (0.21-0.85)   PPV ⩾ 10.1     Analysis with PiCCO2                         57.00
  13      Song et al.^[@bibr32-1179548420901518]^             2014   17   23   12   17   40   0.74 (0.54-0.87)   0.71 (0.47-0.87)   0.74 (0.58-0.90)   PPV ⩾ 13       Analysis with computer software              57.50
  14      Ibarra-Estrada et al.^[@bibr33-1179548420901518]^   2015   15   30   23   29   59   0.5 (0.33-0.67)    0.79 (0.62-0.90)   0.63               PPV ⩾ 14       Analysis of the monitored arterial tracing   50.80
  15      Liu et al.^[@bibr34-1179548420901518]^              2016   35   52   37   44   96   0.67 (0.54-0.78)   0.84 (0.71-0.92)   0.78 (0.69-0.86)   PPV ⩾ 10       Analysis with PiCCO                          54.16
  16      Myatra et al.^[@bibr35-1179548420901518]^           2017   12   16   13   14   30   0.75 (0.51-90)0.   0.93 (0.69-99)0.   0.91 (0.81-0)1.    PPV ⩾ 11.5     Analysis with computer software              53.33
  17      Biais et al.^[@bibr36-1179548420901518]^            2017   12   20   18   21   41   0.60 (0.36-0.78)   0.86 (0.65-0.95)   0.75 (0.60-0.90)   PPV \>9        Analysis with computer ProAQT                48.78
  18      Biais et al.^[@bibr37-1179548420901518]^            2017   15   28   41   60   88   0.54 (0.39-0.78    0.68 (0.56-0.79)   0.65 (0.53-0.78)   PPV \>10       Analysis with computer Pulsioflex            31.81
  19      Yonis et al.^[@bibr38-1179548420901518]^            2017   3    9    8    10   19   0.33 (0.12-0.65)   0.8 (0.49-0.94)    0.49 (0.21-0.77)   PPV \>10       Analysis with computer software              47.36

Abbreviations: tn, true negative; tp, true positive; PPV, pulse pressure variation.

Values are expressed as pooled value (95% confidence interval). AUC; area under curve; n1, number of patients who were positive fluid responsiveness; n2, number of patients who were negative fluid responsiveness; nt, number total of patients included.

Calculated.

The data of sensitivity, specificity, and DOR are shown in [Figures 2](#fig2-1179548420901518){ref-type="fig"} to [4](#fig4-1179548420901518){ref-type="fig"} and in [Table 2](#table2-1179548420901518){ref-type="table"}.

![Sensitivity of pulse pressure variation in patients with tidal volume ⩽8 mL kg^−1^.](10.1177_1179548420901518-fig2){#fig2-1179548420901518}

![Specificity of pulse pressure variation in patients with tidal volume ⩽8 mL kg^−1^.](10.1177_1179548420901518-fig3){#fig3-1179548420901518}

![Diagnostic odds ratio of pulse pressure variation in patients with tidal volume ⩽8 mL kg^−1^.](10.1177_1179548420901518-fig4){#fig4-1179548420901518}

Risk of bias within studies {#section21-1179548420901518}
---------------------------

The risk of bias was low in most of the included studies. Two studies were at high risk of bias in the item of patient selection and flow and timing (see additional [Supplemental Table 1](http://journals.sagepub.com/doi/suppl/10.1177/1179548420901518)).

Syntheses of results {#section22-1179548420901518}
--------------------

The cut-off point average of PPV was 10.28%. Pooled sensitivity was 0.65 (95% CI: 0.57-0.73) by the random-effects model. The pooled specificity was 0.79 (95% CI: 0.73-0.84) by the random-effects model. The pooled DOR was 7.49 (95% CI: 4.50-12.45) by the random-effects model. The studies revealed moderate heterogeneity (*Q* = 42.21, degrees of freedom \[df\] = 18, *P* = .001; *I*^2^ = 57.4, 95% CI: 28.9-74.4). Fitted sensitivity was 0.65 (95% CI: 0.57-0.73, *P* \< .01), whereas the fitted specificity was 0.79 (95% CI: 0.73-0.84, *P* \< .001). The AUC was 0.75 ([Figure 5](#fig5-1179548420901518){ref-type="fig"}).

![Summary ROC curve. Solid closed curve: 95% confidence region; dotted closed curve: 95% prediction region; solid line: summary ROC curve; open circle: summary estimate; close circle: study.](10.1177_1179548420901518-fig5){#fig5-1179548420901518}

Risk of bias across studies {#section23-1179548420901518}
---------------------------

Two studies showed a specificity of 100%,^[@bibr24-1179548420901518],[@bibr35-1179548420901518]^ and 1 study showed a sensitivity of 100%.^[@bibr17-1179548420901518]^ Their specificity and sensitivity needed to decrease to values nearer to 0.9 to calculate their standard error and perform an asymmetry analysis. We found asymmetry in the contour-enhanced funnel plot ([Figure 6](#fig6-1179548420901518){ref-type="fig"}), and it was statistically significant (*P* \< .01). The asymmetry was by publication bias; we found 4 studies with *P* \> .1 versus 15 studies with *P* \< .1, and then the asymmetry was fitted by the trim-and-fill method. We found a fitted DOR by the random-effects model (5.5; 95% CI: 3.08-10.01, *P* \< .001; [Figure 7](#fig7-1179548420901518){ref-type="fig"}).

![Contour enhanced funnel plot for a meta-analysis of pulse pressure variation for prediction of fluid responsiveness in patients with tidal volume ⩽8 mL kg^−1^. Filled circles show an estimated treatment effect (Log diagnostic odds ratio) and its precision (standard error). In addition to individual study results, the fixed-effect estimates (vertical dashed line) with 95% confidence interval limits (diagonal dashed lines) and the random-effects estimate (vertical dotted line) are shown in the figure.](10.1177_1179548420901518-fig6){#fig6-1179548420901518}

![Funnel plot for meta-analysis analysis of pulse pressure variation for prediction of fluid responsiveness in patients with tidal volume ⩽8 mL kg^−1^ after applying the trim-and-fill method. Filled circles in the figure show trials included in the meta-analysis, whereas open circles in the figure show unpublished trials.](10.1177_1179548420901518-fig7){#fig7-1179548420901518}

Additional analysis {#section24-1179548420901518}
-------------------

When we performed a subgroup and meta-regression analysis, we found that lung compliance was associated with an improvement in its operative performance (DOR = 13.14 \[95% CI: 6.48-26.65, *P* = .058 by random-effects, *P* = .03 by fixed-effect\]); see additional [Supplemental Table 2](http://journals.sagepub.com/doi/suppl/10.1177/1179548420901518). Neither clinical setting nor tidal volume was associated with a change in its operative performance. Also, We found 2 outlier studies^[@bibr25-1179548420901518],[@bibr30-1179548420901518]^; these were a source of heterogeneity.

We did not find a correlation between sensitivity and specificity among the studies included (ρ = 0.11, *P* = .63). Moreover, the slope found by the Moses-Shapiro-Littenberg method was not statistically significant (*P* = .465).

Discussion {#section25-1179548420901518}
==========

This systematic review and meta-analysis suggest a fair operative performance of PPV on fluid responsiveness in patients mechanically ventilated at Vt ⩽8 mL kg^−1^.

Respiratory variations in stroke volume have been shown to be associated with preload dependency in mechanically ventilated patients without spontaneous breathing efforts. Pulse pressure variation could be considered, in some extent, a surrogate of stroke volume variation (SVV), and it might predict fluid responsiveness better than static indices of cardiac preload.^[@bibr39-1179548420901518][@bibr40-1179548420901518]-[@bibr41-1179548420901518]^ However, SVV and PPV are generated by respiratory-induced variations, which might be limited when mechanical ventilation is provided at low tidal volumes. Thus, the reliability of PPV could be theoretically limited in mechanically ventilated patients with increased lung elastance or under conditions in which mechanical ventilation at low tidal volume is selected. Several meta-analyses assessed the operative performance of PPV as a predictor of intravenous fluid responsiveness.^[@bibr11-1179548420901518][@bibr12-1179548420901518]-[@bibr13-1179548420901518]^ Nevertheless, studies incorporated in such meta-analyses included patients using a wide variety of tidal volumes. For example, Marik and collaborators included patients with Vt \>7 mL kg^−1^, whereas other authors included mechanically ventilated patients at Vt from 4.9 to 12 mL kg^−1^ and even \>8 mL kg^−1^.^[@bibr12-1179548420901518],[@bibr13-1179548420901518]^ Conversely, we focused on studies including patients ventilated at Vt ⩽8 mL kg^−1^, and we also extended the search to the perioperative setting. As suggested by our results, PPV exhibits a fair operative performance in mechanically ventilated patients at such tidal volumes. Surprisingly, such operative performance was not as bad as expected, which suggests that some patients included in the studies should be highly preload dependent. Thus, although some physicians could consider the sensitivity and specificity of the PPV as low in this clinical setting, PPV can retain some capacity to predict fluid responsiveness in cases of a high preload dependence in patients ventilated with a tidal volume ⩽8 mL kg^−1^.

Variations in Vt influences PPV.^[@bibr42-1179548420901518]^ De Backer et al suggested that low Vt (⩽8 mL kg^−1^) decreases the operative performance of PPV to predict fluid responsiveness,^[@bibr16-1179548420901518]^ whereas other studies have shown different results.^[@bibr24-1179548420901518],[@bibr26-1179548420901518],[@bibr28-1179548420901518],[@bibr30-1179548420901518]^ Our meta-analysis confirms a fair performance of PPV to predict fluid responsiveness when mechanical ventilation is set at Vt ⩽8 mL kg^−1^. However, some strategies could improve such performance, and although these are out of the scope of this meta-analysis, we can mention the adjusting of PPV by the changes in pleural pressure^[@bibr34-1179548420901518]^ and the use of "tidal volume challenges" consisting in transitory increases in Vt to evaluate variations in PPV.^[@bibr35-1179548420901518]^ Nevertheless, such transitory increments of Vt could be not harm-free, and there are no broad data confirming its reliability.

So, the practical question would be, "What can we do to predict fluid responsiveness in mechanically ventilated patients with tidal volumes lower than 8 mL kg^−1^?" One possibility would be using low cut-offs for PPV to identify responders and nonresponders such as suggested by De Backer et al.^[@bibr16-1179548420901518]^ However, lower cut-offs might be more profoundly influenced by small errors in measurements. Another possibility might be to consider the traditional cut-off values (ie, 12%), expecting a low sensitivity but a convenient specificity.^[@bibr24-1179548420901518]^ Unfortunately, data showed in the studies included in our meta-analysis do not provide sufficient information to conduct additional analysis using different cut-off points.

Significant limitations or advantages can result from different statistical strategies to perform meta-analyses, comparing the efficacy of diagnostic tests.^[@bibr43-1179548420901518],[@bibr44-1179548420901518]^ We found moderate heterogeneity between studies, which decreased when we removed 2 outlier ones. Importantly, we did not find another source to clinical heterogeneity by analysis of subgroups and meta-regression; also, we did not find a threshold effect and methodological heterogeneity because, within the quality assessment of the included studies, the risk of bias was low in most of them. All of these reflect the strength of our results.

Our meta-analysis has some limitations. First, most studies included represent small and heterogeneous populations. Second, most of such studies did not evaluate the coexistence of other limitations of PPV, such as right-heart failure, intra-abdominal hypertension, increased lung elastance, or even high RRs, which might limit the conclusions. Moreover, the information retrieved from these studies did not allow exploring other sources of clinical heterogeneity potentially influencing the operative performance of PPV as a predictor of fluid responsiveness in patients mechanically ventilated at Vt lower than 8 mL kg^−1^. Third, the information provided in the studies included is not enough to conduct new analysis searching for different cut-off points predicting fluid responsiveness in these particular and prevailing conditions.

Future investigations should resolve some questions about the predictors of fluid intravenous responsiveness in patients under protective ventilatory strategies and limited respiratory system and lung elastance.

Conclusions {#section26-1179548420901518}
===========

Our meta-analysis shows a fair operative performance of PPV as a predictor of intravenous fluid responsiveness in critical care and perioperative patients ventilated with a tidal volume ⩽8 mL kg^−1^ without respiratory effort and arrhythmias.
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